COMMUNITY HEALTH SYSTEMS INC (CYH) Stock Fundamental Analysis
NYSE:CYH - New York Stock Exchange, Inc. - US2036681086 - Common Stock - Currency: USD
Taking everything into account, CYH scores 3 out of 10 in our fundamental rating. CYH was compared to 102 industry peers in the Health Care Providers & Services industry. While CYH is still in line with the averages on profitability rating, there are concerns on its financial health. CYH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CYH has reported negative net income.
In the past year CYH had a positive cash flow from operations.
In multiple years CYH reported negative net income over the last 5 years.
Of the past 5 years CYH 4 years had a positive operating cash flow.
1.2 Ratios
CYH has a worse Return On Assets (-3.51%) than 63.73% of its industry peers.
The Return On Invested Capital of CYH (5.86%) is better than 62.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CYH is below the industry average of 9.53%.
The last Return On Invested Capital (5.86%) for CYH is above the 3 year average (5.27%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.51% | ||
| ROE | N/A | ||
| ROIC | 5.86% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
1.3 Margins
CYH has a Operating Margin of 6.76%. This is in the better half of the industry: CYH outperforms 71.57% of its industry peers.
CYH's Operating Margin has been stable in the last couple of years.
CYH has a better Gross Margin (84.61%) than 96.08% of its industry peers.
In the last couple of years the Gross Margin of CYH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.76% | ||
| PM (TTM) | N/A | ||
| GM | 84.61% |
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CYH is still creating some value.
The number of shares outstanding for CYH has been increased compared to 1 year ago.
Compared to 5 years ago, CYH has more shares outstanding
CYH has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.81, we must say that CYH is in the distress zone and has some risk of bankruptcy.
CYH has a worse Altman-Z score (0.81) than 73.53% of its industry peers.
CYH has a debt to FCF ratio of 74.55. This is a negative value and a sign of low solvency as CYH would need 74.55 years to pay back of all of its debts.
CYH has a Debt to FCF ratio of 74.55. This is in the lower half of the industry: CYH underperforms 62.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 74.55 | ||
| Altman-Z | 0.81 |
ROIC/WACC1.05
WACC5.61%
2.3 Liquidity
A Current Ratio of 1.44 indicates that CYH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.44, CYH is in line with its industry, outperforming 49.02% of the companies in the same industry.
CYH has a Quick Ratio of 1.30. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
CYH has a Quick ratio (1.30) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.36% over the past year.
CYH shows a small growth in Revenue. In the last year, the Revenue has grown by 1.05%.
Measured over the past years, CYH shows a decrease in Revenue. The Revenue has been decreasing by -0.89% on average per year.
EPS 1Y (TTM)16.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%0.61%
3.2 Future
The Earnings Per Share is expected to grow by 27.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.12% on average over the next years.
EPS Next Y75.73%
EPS Next 2Y41.56%
EPS Next 3Y27.75%
EPS Next 5YN/A
Revenue Next Year-1.11%
Revenue Next 2Y1.16%
Revenue Next 3Y2.12%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
CYH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 977.72, the valuation of CYH can be described as expensive.
CYH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CYH is more expensive than 62.75% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CYH to the average of the S&P500 Index (21.94), we can say CYH is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 977.72 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CYH is valued a bit cheaper than the industry average as 75.49% of the companies are valued more expensively.
98.04% of the companies in the same industry are more expensive than CYH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.65 | ||
| EV/EBITDA | 8.61 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CYH does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CYH's earnings are expected to grow with 27.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.56%
EPS Next 3Y27.75%
5. Dividend
5.1 Amount
No dividends for CYH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.95
-0.26 (-6.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.45%
Inst Owner Change-0.51%
Ins Owners8.24%
Ins Owner Change4.7%
Market Cap554.22M
Analysts70
Price Target4.08 (3.29%)
Short Float %10.5%
Short Ratio4.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-272.69%
Min EPS beat(2)-607.99%
Max EPS beat(2)62.61%
EPS beat(4)1
Avg EPS beat(4)-161.63%
Min EPS beat(4)-607.99%
Max EPS beat(4)62.61%
EPS beat(8)3
Avg EPS beat(8)-188.26%
EPS beat(12)4
Avg EPS beat(12)-665.99%
EPS beat(16)8
Avg EPS beat(16)-256.1%
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.99%
Max Revenue beat(2)2.67%
Revenue beat(4)3
Avg Revenue beat(4)0.92%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)2.67%
Revenue beat(8)5
Avg Revenue beat(8)0.68%
Revenue beat(12)5
Avg Revenue beat(12)-0.46%
Revenue beat(16)8
Avg Revenue beat(16)-0.19%
PT rev (1m)-4.9%
PT rev (3m)-9.48%
EPS NQ rev (1m)-45.41%
EPS NQ rev (3m)-208.94%
EPS NY rev (1m)-9.62%
EPS NY rev (3m)-174.51%
Revenue NQ rev (1m)-0.97%
Revenue NQ rev (3m)-3.66%
Revenue NY rev (1m)-0.56%
Revenue NY rev (3m)-2.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 977.72 | ||
| P/S | 0.04 | ||
| P/FCF | 3.65 | ||
| P/OCF | 1.1 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.61 |
EPS(TTM)-0.92
EYN/A
EPS(NY)0
Fwd EY0.1%
FCF(TTM)1.08
FCFY27.43%
OCF(TTM)3.59
OCFY90.94%
SpS90.19
BVpS-13.71
TBVpS-40.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.51% | ||
| ROE | N/A | ||
| ROCE | 7.42% | ||
| ROIC | 5.86% | ||
| ROICexc | 6.09% | ||
| ROICexgc | 9.25% | ||
| OM | 6.76% | ||
| PM (TTM) | N/A | ||
| GM | 84.61% | ||
| FCFM | 1.2% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
ROICexc(3y)5.3%
ROICexc(5y)5.61%
ROICexgc(3y)7.93%
ROICexgc(5y)8.5%
ROCE(3y)6.68%
ROCE(5y)6.87%
ROICexcg growth 3Y-11.89%
ROICexcg growth 5Y0.9%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y0.93%
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
F-Score4
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 74.55 | ||
| Debt/EBITDA | 8.49 | ||
| Cap/Depr | 73.95% | ||
| Cap/Sales | 2.78% | ||
| Interest Coverage | 1.04 | ||
| Cash Conversion | 37.87% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 0.81 |
F-Score4
WACC5.61%
ROIC/WACC1.05
Cap/Depr(3y)81.42%
Cap/Depr(5y)81.99%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next Y75.73%
EPS Next 2Y41.56%
EPS Next 3Y27.75%
EPS Next 5YN/A
Revenue 1Y (TTM)1.05%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%0.61%
Revenue Next Year-1.11%
Revenue Next 2Y1.16%
Revenue Next 3Y2.12%
Revenue Next 5YN/A
EBIT growth 1Y-7.97%
EBIT growth 3Y-12.97%
EBIT growth 5Y-1.39%
EBIT Next Year57.42%
EBIT Next 3Y19.52%
EBIT Next 5YN/A
FCF growth 1Y164.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y147.06%
OCF growth 3YN/A
OCF growth 5Y4.51%